Anthony P. Bossis, Ph.D., is a clinical psychologist and Clinical Assistant Professor of Psychiatry at NYU School of Medicine, an Adjunct Professor of Classics and Religious Studies at the University of Ottawa, and an Investigator at The Lundquist Institute for Biomedical Innovation at UCLA. Since 2006, he has conducted FDA-approved clinical research with the psychedelic compound psilocybin. His primary psychedelic research interests are the treatment of end-of-life existential distress and advancing our understanding of consciousness, meaning, and spirituality. Dr. Bossis was director of palliative care research and co-principal investigator on the landmark 2016 clinical trial demonstrating a significant reduction in emotional distress from a single psilocybin session in persons with cancer, specifically, a rapid decrease in depression, anxiety, hopelessness, and demoralization along with improvements in spiritual well-being and quality of life. He is the study director and the lead therapist on an FDA-approved clinical trial investigating a psilocybin-generated mystical experience upon religious leaders. Dr. Bossis is a training supervisor of psychotherapy at NYU-Bellevue Hospital Center and co-founder and former co-director of the Bellevue Hospital Palliative Care Service. He is a faculty member at The Center for Psychedelic Therapies and Research at the California Institute of Integral Studies, the Art of Dying Institute in NYC, and the graduate psychedelic studies program at the University of Ottawa. He is on the editorial board of the Journal of Humanistic Psychology and a guest editor for the journal’s Special Series on Psychedelics. Dr. Bossis has a long-standing interest in comparative religion, mystical experience, and the interface of psychology and spirituality. He maintains a private psychotherapy and consulting practice in NYC. Anthony is a proud Greek American whose grandparents hail from the beautiful island of Limnos.